High Content Screening Market worth US$2.19 billion in 2030 with 7.5% CAGR
"The prominent players operating in the high content screening market are Danaher Corporation (US), Revvity, Inc. (US), BD (US), Carl Zeiss AG (Germany), Merck KGaA (Germany), and Thermo Fisher Scientific, Inc. (US), among others."
Browse 363 market data Tables and 31 Figures spread through 358 Pages and in-depth TOC on "High Content Screening Market by Product & Services (Instrument (Cell Imaging, Analysis System), Consumables (Reagents & Assay Kits, Microplates), Software), Application (Drug Discovery & Development, Toxicology), End User - Global Forecast to 2030
The global High Content Screening Market, valued at US$1.47 billion in 2024, is forecasted to grow at a robust CAGR of 7.5%, reaching US$1.52 billion in 2025 and an impressive US$2.19 billion by 2030. Al and machine learning advancements enhance image analysis capabilities, improving the accuracy and efficiency of high-throughput screening. The expanding applications of HCS in personalized medicine, oncology research, and cell- based assays contribute to market growth. Furthermore, government funding for cell-based research and the rising prevalence of chronic diseases are increasing the adoption of HCS technologies across various research fields.
Key segments positively impacting the market include high-content imaging platforms, which dominate due to their critical role in drug discovery and cellular research. Among applications, drug discovery and development lead the market, with pharmaceutical and biotechnology companies being the largest end users due to their extensive R&D investments. The rising adoption of toxicology screening and target identification further supports market growth.
Browse in-depth TOC on " High Content Screening Market"
363 - Tables
31 - Figures
358 - Pages
By Based on cell detection and analysis system segment, the market is segmented by instrument into high content imaging platforms, cell detection and analysis systems, and cell imaging systems. The high content imaging platforms segment dominated the market in 2024. High content imaging platforms hold a significant share in the market owing to their critical role in cellular analysis, drug discovery, and phenotypic screening. These platforms enable high-throughput imaging of live and fixed cells, providing detailed cellular morphology and functional insights necessary for drug screening, toxicity assessment, and disease modelling.
By Based on Primary and Secondary screening, the application segment is divided into drug discovery & development applications, toxicology, and basic research. The drug discovery & development application segment is further divided into primary screening and secondary screening, target identification and validation, compound profiling, and other drug discovery & development applications. The rising focus on precision medicine, personalized therapies, and high-throughput screening applications has reinforced the demand for high content imaging systems in research and clinical settings.
By Based on end user, the market is segmented into pharmaceutical & biotechnology companies, academic & government institutes, and CROs & CDMOs. pharmaceutical & biotechnology companies dominated the segment in 2024 and is anticipated to grow at the highest CAGR during the forecast period of 2025-2030. Dominance of the segment is attributable to increasing complexity of drug candidates, particularly in oncology, immunology, and neurological disorders, which has further boosted the demand for HCS in cellular imaging and phenotypic screening. Moreover, the growing trend of precision medicine and biologics development also contributes to the increased utilization of HCS technologies, which is supporting the segment growth in high content screening market.
By geography, the high content screening market is segmented by region into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America dominated the market due to a strong presence of leading academic institutions and market players, substantial investments in biotechnology and pharmaceutical research, and advanced healthcare infrastructure. Asia-Pacific (APAC) is witnessing rapid growth, due to the rising prevalence of chronic diseases, increasing healthcare investments, and expanding research capabilities. Countries like China, India, and Japan are experiencing substantial advancements in biotechnology and drug discovery, supporting to the growing demand for high content screening technologies.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=42710391
The prominent players operating in the high content screening market are Danaher Corporation (US), Revvity, Inc. (US), BD (US), Carl Zeiss AG (Germany), Merck KGaA (Germany), and Thermo Fisher Scientific, Inc. (US), among others.
Danaher (US)
is one of the leading players in the high content screening market. The company has a presence in more than 60 countries and offers a diversified product portfolio of instruments and software in the high content screening market. Danaher strongly focuses on organic and inorganic growth strategies to maintain a dominant position in the market. The company operates in the market through Beckman Coulter, Molecular Devices, and Integrated DNA Technologies, among others. Danaher's robust global distribution network and dedicated customer support help the company to maintain its dominant position in the market.
Revvity, Inc. (US)
is one of the dominant players in the high content screening market. The company has a global presence in more than 150 countries and has diversified products for the high content screening market. The company's product offerings include instruments, software, and consumables such as automated cell counter, flow cytometer, microscope, cell imaging systems, and microplate readers. A robust global distribution network and customer-centric approach ensure Revvity serves diverse sectors, including academia, biotechnology, and pharmaceuticals.
For more information, Inquire Now!
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
an hour ago
- Globe and Mail
New Buy Rating for Broadcom (AVGO), the Technology Giant
Mizuho Securities analyst Vijay Rakesh reiterated a Buy rating on Broadcom (AVGO – Research Report) yesterday and set a price target of $310.00. The company's shares closed yesterday at $259.93. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Rakesh is a 5-star analyst with an average return of 11.8% and a 49.30% success rate. Rakesh covers the Technology sector, focusing on stocks such as Nvidia, Advanced Micro Devices, and Broadcom. Currently, the analyst consensus on Broadcom is a Strong Buy with an average price target of $256.04. The company has a one-year high of $265.43 and a one-year low of $128.50. Currently, Broadcom has an average volume of 29.27M. Based on the recent corporate insider activity of 57 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of AVGO in relation to earlier this year. Most recently, in April 2025, Mark David Brazeal, the Chief Legal & Corp Affairs Ofc of AVGO sold 25,000.00 shares for a total of $4,500,000.00.
Globe and Mail
2 hours ago
- Globe and Mail
Silver's Options Sizzle: Are Traders Betting on a Breakout?
A notable wave of trading activity swept through several silver-linked assets in early June. Investors saw a significant jump in call option volumes for multiple silver-related equities. Call options give the holder the right, not the requirement, to buy an asset, such as a stock or ETF share, at a pre-set price by a specific date. When call volume spikes, it often signals that some traders believe the asset's price is poised to rise. This unusual call option volume and increased investor interest in multiple stocks and ETFs at the same time warrant a closer look to see what's stirring in the silver sector. Unpacking the Action: A Look at Specific Silver Plays The heightened call option volume in early June varied across multiple silver-related securities, each telling a slightly different story. Separately, they tell four stories of bullish catalysts and heightened investor sentiment, but when combined, they start to reveal the bigger picture of a sector accumulating interest and investment. iShares Silver Trust: A Price Play on Silver Bullion? [content-module:CompanyOverview|NYSE:AG] The iShares Silver Trust (NYSEARCA: SLV), an ETF that aims to track the price of silver bullion, saw 599,279 call option contracts traded. This volume was 57.8% above its usual average. The high call volume may suggest that some traders expect silver prices to rebound soon or are preparing for further price fluctuations. Because SLV tracks physical silver, this option's activity directly reflects views on the metal itself, likely influenced by broader economic news or general market coverage. First Majestic: Mining News Ignites Options Interest? [content-module:CompanyOverview|NYSE:AG] First Majestic Silver Corp. (NYSE: AG), a company focused mainly on silver production, experienced a call option volume of 39,607 contracts, an 80.9% increase from its average. First Majestic's stock price has also climbed around 18% to $7.28 during the first week of June, with a high trading volume. This mix of soaring call options, a rising stock price, and heavy trading often points to strong positive sentiment. Recent good news from the company has also likely played a role. For instance, on May 28, 2025, First Majestic announced a significant gold-silver discovery at its Santa Elena property. This, along with strong financial results from the first quarter of 2025, could lead traders to expect more gains from the stock. Pan American Silver: Big Deal Draws Options Traders? [content-module:CompanyOverview|NYSEARCA:SILJ] Pan American Silver Corp. (NYSE: PAAS), a large, diversified silver producer, recorded 9,098 call option contracts traded, up 25.7% from its average. The company's stock price also rose, gaining nearly 10% in early June. This increased call activity, alongside positive news indicators, suggests investors are reacting well to recent company moves. A key factor is likely Pan American's May 11, 2025, announcement of a deal to acquire MAG Silver Corp. for $2.1 billion. This strategic acquisition is expected to significantly boost Pan American's silver output and potential future earnings, which could, in turn, lift its stock price and attract optimistic options bets. Junior Miners: High Hopes for Smaller Players? [content-module:CompanyOverview|NYSEARCA:SILJ] The Amplify Junior Silver Miners ETF (NYSEARCA: SILJ), which holds smaller silver mining and exploration companies, saw its call option volume hit 14,925 contracts. This was a striking 97.7% leap above its average, and it was also the most significant percentage increase among these assets. SILJ's price also increased by around 10% in early June. This dramatic percentage jump in calls for SILJ points to strong speculative interest in this part of the silver market. Junior miners often have stock prices that move more sharply with silver prices. The high option activity here suggests that some traders may be betting on substantial returns from these smaller firms if silver prices continue to climb or if positive news persists for the sector. Beyond Options: What This Means for the Silver Market When call option volume rises sharply across different types of silver assets, it can signal a broader increase in investor focus on the entire silver sector. Some traders may be positioning for potential price gains. Silver's appeal comes from several areas. Demand from industries utilizing silver in green technologies, such as solar panels, electronics and the automotive sector, remains strong. Silver is also a well-known precious metal. It is often regarded as a valuable investment that retains its value, especially during economic uncertainty or rising inflation. These core factors continue to support interest in the metal. What Spiking Call Volumes Say About Silver's Next Move The notable surge in call option activity across our four assets in early June clearly shows heightened investor focus on the silver sector. This flurry of bullish bets, reflected in the increased demand for call options, suggests that a market segment is positioning for potential upward price movements in silver bullion and mining equities. Whether driven by specific company news or broader shifts in sentiment towards precious metals, the data points to a renewed speculative interest. The significant percentage increase in call volume underscores a willingness among some traders to embrace higher-risk, potentially higher-reward scenarios within the silver space. Ultimately, this concentrated options activity serves as a strong indicator that silver and its related securities captured significant market attention. At the same time, the direct motivations behind each trade can vary, the collective signal points towards a period of dynamic interest and re-evaluation for the silver complex. How these expectations play out will depend on ongoing market fundamentals, company performance, and the broader economic landscape, ensuring that the silver narrative will remain one to watch. Where Should You Invest $1,000 Right Now? Before you make your next trade, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.
Globe and Mail
3 hours ago
- Globe and Mail
Why Dollar General Stock Zoomed Nearly 17% Higher This Week
According to data compiled by S&P Global Market Intelligence, discount retailer Dollar General 's (NYSE: DG) share price ballooned by almost 17% across the trading week. In retrospect that wasn't surprising, as the company simply crushed it in its latest earnings report, and analysts fell over themselves publishing bullish new takes on its stock. The dollars rolled in Dollar General delivered its first-quarter figures Tuesday morning, and investors couldn't wait to pile into its shares. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » This was understandable, because those fundamentals were solid. The retailer's net sales climbed more than 5% higher year over year to land at $10.4 billion. This was on the back of a 2%-plus rise in same-store sales, always a core performance metric in the retail industry. Profitability headed north too, with GAAP net income rising almost 8% to slightly under $392 million. In per-share terms, Dollar General earned $1.78. Both headline figures topped the consensus analyst estimates. On average, pundits tracking the stock were modeling $10.25 billion on the top line, and only $1.46 per share for net income. Some of those pundits might not be underestimating Dollar General quite so much. A clutch of them raised their price targets on the stock, with a few even upgrading their recommendations. One of the upgrades was enacted by Oppenheimer 's Rupesh Parikh, who now feels the company is worthy of an overperform (buy) rating at $130 per share, where previously it was only rated a perform (hold). Solid and sustainable According to reports, Parikh was not only impressed by Dollar General's ability to sustain 2% to 3% comparable sales growth figures, he feels it's an excellent play in a recessionary environment. That's been a persistent fear lately of numerous economists and more than a few investors, given the current shakiness in the global and domestic economies. Dollar General definitely seems as if it's on a roll, and it might just become a hot, go-to retailer if those gloomy predictions come true. It's absolutely a stock to consider for our times. Should you invest $1,000 in Dollar General right now? Before you buy stock in Dollar General, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Dollar General wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $674,395!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $858,011!* Now, it's worth noting Stock Advisor 's total average return is997% — a market-crushing outperformance compared to172%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 2, 2025
